RRM reduced breast cancer risk by 80 per cent, and the probability of dying of breast cancer 15 years after risk-reducing mastectomy was less than one per cent | Health
1 in 25 people had a genotype linked to short lifetime, which includes BRCA2 and LDLR genes, that reduced lifespan by seven years, and six years respectively.
(The Conversation) – Have you ever wondered why certain medications don’t seem to work as well for you as they do for others? This variability in drug response is what pharmacogenomic testing hopes to explain by looking at the genes within your DNA. Pharmacogenomics, or PGx, is the study of how genes affect your response to medications. Genes […]
Pharmacogenetic testing is a form of precision medicine, using your genes to personalize your care. D3Damon/E+ via Getty ImagesHave you ever wondered why certain medications don’t seem to work as well for you as they do for others? This variability in drug response is what pharmacogenomic testing hopes to explain by looking at the genes within your DNA. Pharmacogenomics, or PGx, is the study of how genes affect your response to medications. Genes are segments of DNA that serve as an instruction